# FOSAPREPITANT DIMEGLUMINE
> **ANDA212309** · Abbreviated New Drug Application (Generic) · Sponsor: BE PHARMS · Approved 2019-09-05
## Drug
- **FDA Application Number:** ANDA212309
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FOSAPREPITANT DIMEGLUMINE
- **Generic name:** FOSAPREPITANT
- **Active ingredients:** FOSAPREPITANT DIMEGLUMINE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BE PHARMS
- **Manufacturer:** BE Pharmaceuticals Inc.
- **First approval:** 2019-09-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212309)
---
*AI Analytics · CC0 1.0*